The Tianjin TEDA Biomedical Engineering Company Limited's board announced that the term of the service contracts of all the current directors and supervisors will expire on 31 December 2016. Save for Mr. Wang Shuxin (an executive Director), Mr. Guan Tong, Mr. Wu Chen and Mr. Chan Kin Sang (each an independent non- executive Director), Mr. Gao Xianbiao (a Supervisor) and Mr. Liu Renmu (a non-executive Director who will be re-designated as an executive director of the Company), who will not offer themselves for re-election, all other (i) executive Directors and non-executive Directors of the company and Supervisors and independent Supervisors of the company will offer themselves for re-election. Mr. Wang Shuxin will not offer himself for the re-election as an executive Director. Each of Mr. Guan Tong, Mr. Wu Chen and Mr. Chan Kin Sang will not offer himself for the re-election as an independent non-executive Director as each of them intends to devote more time to develop his personal business. Given that Mr. Wang Shuxin, Mr. Guan Tong, Mr. Wu Chen, Mr. Chan Kin Sang and Mr. Gao Xianbiao will not offer themselves for re-election and their service terms will expire on 31 December 2016, the Board proposes to re-designate Mr. Liu Renmu as a non-executive Director, appoint Mr. Li Ximing as a non-executive Director, appoint each of Mr. Li Xudong, Mr. Duan Zhongpeng and Ms. Gao Chun as an independent non-executive Director, and Ms. Feng Ling as an independent Supervisor of the Company to fill up the vacant positions. Subject to the approval of the Shareholders at the EGM by way of ordinary resolutions, all proposed Directors and Supervisors of the Company will be appointed for a term of three years commencing from 1 January 2017 and expiring on 31 December 2019.